Magnetic resonance imaging findings of pituitary hyperplasia due to primary hypothyroidism.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao

Department of Radiology, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.

Published: October 2012

AI Article Synopsis

  • The study investigates the effects of primary hypothyroidism on pituitary hyperplasia through clinical and MRI findings, reviewing 11 patients diagnosed between 2008 and 2011.
  • Key clinical features included growth arrest, mental retardation, fatigue, and hormonal abnormalities, with MRI revealing characteristic symmetric enlargement of the pituitary gland.
  • The research emphasizes the importance of combining MRI results with clinical and lab data to accurately identify pituitary hyperplasia and prevent misdiagnosis.

Article Abstract

Objective: To explore the clinical and magnetic resonance imaging (MRI) findings of pituitary hyperplasia due to primary hypothyroidism.

Method: The clinical presentations, laboratory examinations, and MRI findings of 11 patients with pituitary hyperplasia secondary to primary hypothyroidism diagnosed at our hospitals from the beginning of 2008 to the end of 2011 were retrospectively reviewed.

Results: The clinical manifestations in 11 patients included growth arrest(7/8), mental retardation (6/8), cold intolerance and fatigue(6/11), slightly increased body weight (6/11), galactorrhea (3/11), paramenia (8/9), precocious puberty companying vaginal bleeding (2/2),and blurry vision (3/11). Laboratory investigations revealed grossly increased thyroid stimulating hormone, decreased thyroxine, and slightly elevated prolactin levels in all cases. Thyroid antibody was positive in six cases. On MRI, pituitary mass were detected a large intrasellar with/without suprasellar extension in all patients,showing the characteristic of symmetric enlargement. Spherical shape was viewed in 5 cases,with the height of (12.22 ± 3.12)mm. In the other 6 cases, the pituitary mass with the shape of calabash extended superiorly to suprasellar area, with a height of(18.95 ± 2.23)mm. The signal of pituitary mass was isointense to grey matter both on T1 weighted imaging and T2 weighted imaging. Bright short T1 signal in posterior lobe of pituitary was visible. Pituitary stalk was detected only in 4 cases from MRI without dislocation, while the width of pituitary stalk was within the normal limit.

Conclusions: Pituitary hyperplasia should be considered when homogenous enlargement of the pituitary gland is found on MRI. The integration of MRI findings, clinical manifestations, and laboratory findings is helpful for the proper identification of the primary endocrine disease and thus avoid misdiagnosis.

Download full-text PDF

Source
http://dx.doi.org/10.3881/j.issn.1000-503X.2012.05.006DOI Listing

Publication Analysis

Top Keywords

pituitary hyperplasia
16
mri findings
12
pituitary mass
12
pituitary
11
magnetic resonance
8
resonance imaging
8
findings pituitary
8
hyperplasia primary
8
primary hypothyroidism
8
clinical manifestations
8

Similar Publications

Rare endocrine diseases are complex conditions that require lifelong specialized care due to their chronic nature and associated long-term complications. In Korea, a lack of nationwide data on clinical practice and outcomes has limited progress in patient care. Therefore, the Multicenter Networks for Ideal Outcomes of Pediatric Rare Endocrine and Metabolic Disease (OUTSPREAD) study was initiated.

View Article and Find Full Text PDF

Pituitary gigantism (PG) is a rare endocrine disorder that may present with multiple pituitary hormone abnormalities in pediatric patients. A hallmark presentation is accelerated growth due to growth hormone (GH) excess. Current treatment modalities include surgery, radiation, and medical therapy.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates sleep health in children and adolescents with congenital adrenal hyperplasia (CAH) using wrist actigraphy and sleep questionnaires.
  • It found that these children had poorer sleep duration, efficiency, and more awakenings compared to healthy peers, particularly related to hydrocortisone medication timing.
  • The results indicate that sleep issues are significant for children with CAH, highlighting the need for attention in clinical practice and further research.
View Article and Find Full Text PDF

Pituitary Acrogigantism: From the Past to the Future.

Front Horm Res

November 2024

Department of Endocrinology, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium.

Pituitary acrogigantism is a very rare disease that is caused by chronic growth hormone (GH) axis excess that begins during childhood and adolescence. As such, it represents one of the most severe manifestations of acromegaly. In most cases, acrogigantism is caused by a pituitary adenoma, but hyperplasia can also accompany the adenoma or rarely occur alone.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the glycemic patterns in children with congenital hyperinsulinism (HI) using Continuous Glucose Monitoring (CGM) over a 12-month period to provide better insights for future treatments.
  • It involved 45 patients, revealing a consistent risk of hypoglycemia, especially early in the morning, but showed that CGM did not effectively reduce these episodes and the device's accuracy was found to be poor.
  • Despite high dissatisfaction among patients and families regarding CGM usage, qualitative feedback indicated that it helped them understand glycemic patterns and make behavior adjustments to reduce hypoglycemia.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!